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Available online 2 December 2015Background: Despite the high prevalence of generalized anxiety disorder (GAD) and its negative impact on soci-
ety, its neurobiology remains obscure. This study characterizes the neurostructural abnormalities associatedwith
key symptoms of GAD, focusing on indicators of impaired emotion regulation (excessive worry, poor concentra-
tion, low mindfulness, and physiological arousal).
Methods: These domains were assessed in 19 (16women) GAD patients and 19 healthy controlsmatched for age
and gender, using questionnaires and a low demand behavioral task performed before and after an induction of
perseverative cognition (i.e. worry and rumination). Continuous pulse oximetry was used tomeasure autonomic
physiology (heart rate variability; HRV). Observed cognitive and physiological changes in response to the induc-
tion provided quantiﬁable data on emotional regulatory capacity. Participants underwent structural magnetic
resonance imaging; voxel-based morphometry was used to quantify the relationship between gray matter vol-
ume and psychological and physiological measures.
Results:Overall, GAD patients had lower graymatter volume than controlswithin supramarginal, precentral, and
postcentral gyrus bilaterally. Across the GAD group, increased right amygdala volume was associated with
prolonged reaction times on the tracking task (indicating increased attentional impairment following the induc-
tion) and lower scores on the ‘Act with awareness’ subscale of the Five Facets Mindfulness Questionnaire. More-
over in GAD, medial frontal cortical gray matter volume correlated positively with the ‘Non-react mindfulness’
facet. Lastly, smaller volumes of bilateral insula, bilateral opercular cortex, right supramarginal and precentral
gyri, anterior cingulate and paracingulate cortex predicted themagnitude of autonomic change following the in-
duction (i.e. a greater decrease in HRV).
Conclusions:Results distinguish neural structures associatedwith impaired capacity for cognitive, attentional and
physiological disengagement fromworry, suggesting that aberrant competition between these levels of emotion-
al regulation is intrinsic to symptom expression in GAD.
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Generalized anxiety disorder (GAD) is the most prevalent anxiety
disorder (Kessler et al., 2001; Olesen et al., 2012); yet it remains poorly
understood and, as a result, ismore difﬁcult to treat (Brown et al., 1994).
The most pervasive and distressing symptoms of GAD, associated with
signiﬁcant impairment in daily functioning, are excessive worry, difﬁ-
culties concentrating, and feelings of physiological arousal (Andor
et al., 2008; Stefanopoulou et al., 2014). To date, the extent to which
these key features of GAD reﬂect disruption of common versus unique
underlying mechanisms remains unclear (Forster et al., 2015).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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emotion regulation (and deﬁcits in GAD) is mindfulness (Desrosiers
et al., 2013a; Greeson andBrantley, 2009; Roemer et al., 2009).Mindful-
ness (Brewer et al., 2013) consists of several distinct dimensions (with
symptom counterparts), including the ability to pay attention (difﬁculty
concentrating; (Sugiura, 2004)), the ability to notice experiences in the
present without judging (worry and rumination; (Hoge et al., 2013)),
and the ability to accept negative experience and feelings without
reacting (physiological arousal; (Hazlett-Stevens, 2008)). Consequent-
ly, mindfulness based theories are increasingly incorporated in psycho-
therapeutic treatments to foster emotion regulation skills in GAD
(Kabat-Zinn, 1990).
Symptomsof emotion dysregulation inGAD, expressed across differ-
ent psychophysiological axes, may reﬂect disruption of the degree to
which the origin of symptoms overlap, and may ultimately inform the
targeting of therapeutic interventions. Within the brain, a network
model has been proposed for the integration of autonomic, attentional,
and affective control underlying emotion regulation and dysregulation
(Thayer and Lane, 2000). Despite the evident role of the brain in core
symptomatology of anxiety, the neurobiological studies of GAD patients
are sparse. The few published studies concentrate on the role of amyg-
dala, prefrontal cortex (PFC) and anterior cingulate cortex (ACC)
(reviewed in (Hilbert et al., 2014)). The amygdala is proposed as the
major “fear-circuit” structure (Davis et al., 2010), the PFC as responsible
for frontal overcontrol (perseverative cognition; (Thayer and Lane,
2000)), and the ACC implicated in emotion regulation and autonomic
control (Critchley et al., 2003). Enlargement of the amygdala and
dorsomedial PFC (DMPFC) is reported in adult (Etkin et al., 2009;
Schienle et al., 2011), children, and adolescents with GAD (De Bellis
et al., 2000). Increased gray matter volume is also reported in the supe-
rior temporal gyrus (a region supporting social processing) in pediatric
GAD (De Bellis et al., 2002), while decreased gray matter volume is ob-
servedwithin precuneus andprecentral, orbitofrontal and posterior cin-
gulate gyrus (PCC) in adolescents (Strawn et al., 2013). One study
reported decreased bilateral hypothalamus volumes in GAD adults
(Terlevic et al., 2012).
Few studies investigated the neurostructural correlates of core
symptoms such asworry. DMPFC andACC volume appeared to positive-
ly correlate with self-report levels of worry and beliefs about the useful-
ness of worry (Schienle et al., 2011). A second study reported a positive
correlation between worry levels and medial orbitofrontal cortex
(mOFC), but not dorsolateral PFC (DLPFC) or amygdala volume
(Mohlman et al., 2009).
Neurobiological correlates of mindfulness suggest that individuals
who are more ‘mindful of the present’ are characterized by increased
gray matter volume in right hippocampus/amygdala and bilateral ACC,
yet have reduced graymatter volume in bilateral PCC and the left OFC im-
plying that trait mindfulness is determined by brain regions involved in
executive attention, emotion regulation, and self-referential processing
(Lu et al., 2014). A meta-analysis of morphometric neuroimaging
amongmeditation practitioners found eight brain regions consistently al-
tered in meditators, including key areas for meta-awareness (frontopolar
cortex), exteroceptive and interoceptive body awareness (sensory corti-
ces and insula), memory consolidation and reconsolidation (hippocam-
pus), and emotion regulation (anterior and mid cingulate, OFC) (Fox
et al., 2014). Holzel and colleagues investigated the neural mechanisms
of symptom improvements in GAD following mindfulness training com-
pared to an active control intervention (Hölzel et al., 2013). Mindfulness
training was associated with decreased amygdala and enhanced prefron-
tal activation to emotional stimuli and increased amygdala–prefrontal
connectivity, which is known to be crucial to successful emotion regula-
tion. Importantly, these changes correlatedwith improvements in anxiety
symptoms following the mindfulness training.
Given these premises, we used voxel-based morphometry (VBM) to
characterize gray matter volume differences associated with worry,
sustained attention, mindfulness, and autonomic arousal in GAD andcontrols. We ﬁrst tested for gray matter volume differences between
the two groups, hypothesizing that GAD patients would manifest struc-
tural abnormalities in brain (mainly enlarged amygdala and PFC vol-
umes) compared to controls. Subsequently, we ran a series of
correlational analyses to explore which brain regions showed a signiﬁ-
cant association between the graymatter volume and our key variables.
In this set of analyses, our approach was ﬁrst theory-driven, as we pri-
marily focused on the amygdala and PFC, in light of their established
role in emotional and autonomic regulation and the structural alter-
ations of these structures often described in GAD (Etkin et al., 2009;
Schienle et al., 2011; De Bellis et al., 2000). However, considering that
the structural alterations described in GAD go beyond these two struc-
tures, we subsequently adopted a data-driven approach and described
signiﬁcant results outside the regions of the amygdala and PFC, which
might be even more informative of the biology underlying GAD condi-
tion. We used objective measures of attention; i.e. reaction time (RT)
to infrequent probes within a low demand attentional task (Ottaviani
et al., 2013) and of autonomic control; i.e. HRV derived from pulse ox-
imetry. In both healthy and psychopathological subjects there is evi-
dence for the close mechanistic coupling of autonomic nervous system
control and expression of anxiety symptoms, with functional neuroim-
aging studies highlighting the role of speciﬁc regions including amygda-
la, ACC and insula, in integrating the control and representation of
autonomic arousal with neural and behavioral sensitivity to fear signals
(Garﬁnkel et al., 2014; Makovac et al., 2015; Phelps and LeDoux, 2005).
To overcome the limitations of the few studies conducted on this topic
not only we did not rely on self-report measures of symptoms but we
also included an emotion regulation induction.
2. Methods and materials
2.1. Participants
Forty volunteerswere recruited by public advertisement to take part
in the study. Two participants were excluded because of neuroimaging
and peripheral physiology artifacts. The ﬁnal sample was composed of
19 individuals (16 women, 3 men; mean age = 30.0 ± 6.9 years) who
met diagnostic criteria for GAD and 19 healthy controls (16 women, 3
men; age = 29.2 ± 9.8 years). The prevalence of women in the sample
reﬂects the unequal gender distribution in the examined psychopatho-
logical disorder. All participants were right-handed, native English
speakers, and had normal or corrected-to-normal vision. Exclusion
criteria were: age younger than 18 years, past head injury or neurolog-
ical disorders, prior history of major medical or psychiatric disorder
(other than GAD for the patient group), cognitive impairment, history
of substance or alcohol abuse or dependence, diagnosis of heart disease,
obesity (body mass index N 30 kg/m2), pregnancy, claustrophobia or
other general MRI exclusions. Two GAD participants were included
who use long-term medications (1 citalopram, 1 pregabalin) at the
time of the study. All other patients and controls were medication
free. The average disease duration was 16.78 (±8.01) years and none
of our GAD participants had a formal diagnosis of co-morbid major de-
pressive disorder. All participants provided written informed consent.
The study was approved by the National Research Ethics Service
(NRES) for the National Health Service (NHS) with local approval the
Brighton and Sussex Medical School Research Governance and Ethics
Committee. Participants were compensated for their time.
2.2. Procedure
The Structured Clinical Interview for DSM­IV (SCID) was adminis-
tered to both patient and controls to conﬁrm/exclude the diagnosis of
GAD. Participants then completed a series of questionnaires, were sub-
sequently familiarized with the neuroimaging environment, connected
to the physiological recording equipment, and underwent the MRI
protocol.
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Participants completed questionnaires accessing sociodemographic
and lifestyle (nicotine, alcohol, and caffeine consumption, physical ac-
tivity) information, state and trait anxiety (State-Trait Anxiety Invento-
ry, STAI; (Spielberger et al., 1983)), depression (Beck Depression
Inventory, BDI; (Beck et al., 1988)), trait worry (Penn StateWorryQues-
tionnaire, PSWQ; (Meyer et al., 1990)), and a dispositional measure of
mindfulness (Five Facets Mindfulness Questionnaire, FFMQ; (Baer
et al., 2006)). The FFMQ measures ﬁve mindfulness skills: Non-
reactivity to inner experience, Observing/noticing, Acting with aware-
ness, Describing, and Non-judging of experience. Responses are given
on a 5-point Likert scale (1 = Never or very rarely true, 5 = Very
often or always true). The ﬁve subscales have shown adequate to good
internal consistency (Baer et al., 2006).2.4. MRI protocol
After the structuralMRI brain scan, participants underwent four rep-
etitions of a 6-min low-demand visuomotor attentional tracking task,
each followed by a 5-min resting period (see S1 in the supplementary
online material for a visual representation of the experimental design).
The visuomotor attentional task (adapted from Ottaviani et al., 2013)
required participants to track a circle moving horizontally on the screen
and press a button as fast as possible each time the circle turned red. The
duration of the red circle (target) was 100ms: if participants did not re-
spondwithin that time limit, the circle disappeared and the task contin-
ued. For each target, accuracy and RT were recorded. The level of
difﬁculty was very low to increase the likelihood of episodes of persev-
erative cognition. At the end of each tracking task, participants were re-
quired to report their thoughts during the preceding period using
visual-analogue scales (VAS). After the second or third resting block
participants underwent a recorded verbal induction procedure de-
signed to engender perseverative cognition: “Next I would like you to re-
call an episode that happened in the past year that made you feel sad,
anxious, or stressed, or something that may happen in the future that
worries you. Then, I would like you to think about this episode in detail,
for example about its possible causes, consequences, and your feelings
about it. Please keep thinking about this until the end of the next tracking
task. Thank you. Please take as much time as you need to recall the episode
and press the button whenever you are ready”.
To control for temporal order effects, participants were randomized
according to when the induction occurred.
This induction has beenproved to be particularly effective in evoking
worrisome and ruminative thoughts that have sustained and prolonged
physiological consequences and ﬁndings have been replicated in differ-
ent experimental settings in both healthy and clinical samples
((Ottaviani et al., in press) for a meta-analysis).2.5. Visual analogue scales (VAS)
To assess levels of perseverative cognition occurring prior to and fol-
lowing the induction, participants were asked to rate on four separate
visual analogue 100-point scales “How much, for the duration of the
task, were you”: 1) focused on the task?; 2) distracted by external stim-
uli?; 3) ruminating/worrying?; and 4) distracted by internal thoughts?
The last question had the aim to investigate non-pathological mind
wandering, in light of recent ﬁndings suggesting distinguished physio-
logical signatures of functional mind wandering and maladaptive per-
severative cognition (Ottaviani et al., 2013, 2015a, 2015b) and was
described to participants in terms of “letting their mind just wander,
without getting stuck on any particular thought”.
VAS scores were averaged using before (Pre) and after (Post) induc-
tion ratings.2.6. Physiological data processing
Heartbeats were monitored using MRI-compatible ﬁnger pulse ox-
imetry (8600FO; Nonin Medical), recorded digitally as physiological
waveforms at a sample rate of 1000 Hz (via a CED power 1401, using
Spike2v7 software; Cambridge Electronic Design; Cambridge UK).
Inter-beat-intervals (IBI) values were visually inspected and potential
artifacts were manually removed. The RHRV 4.0 analysis software
(http://rhrv.r-forge.r-project.org/) was used to derive the root mean
square successive difference (RMSSD) a measure of vagally mediated
HRV (Task Force of the European Society of Cardiology and the North
American Society of Pacing and Electrophysiology, 1996). RMSSD has
been demonstrated to be particularly suited to capture autonomic per-
turbation in anxiety disorders (Alvares et al., 2013) even from very
short (down to 10 s) ECG recordings (Nussinovitch et al., 2012) and to
be relatively free of the inﬂuences of respiration (Goedhart et al.,
2007; Penttilä et al., 2001). Thus, RMSSD was obtained for the 20 s
epochs preceding each probe using RHRV 4.0 (http://rhrv.r-forge.r-
project.org) and then averaged using before (Pre) and after (Post) in-
duction values.
2.7. MRI acquisition and preprocessing
The present manuscript focuses on the structural neuroimaging
analyses. Structural brain MRI scans (0.9 mm isometric voxels, 192 sag-
ittal slices, repetition time 11.4 ms, echo time 4.4 ms, inversion time
300ms)were acquired using a Siemens Avanto 1.5 T scanner (32-chan-
nel head coil, Siemens, Erlangen, Germany).
The T1 weighted (MPRAGE) volumes from all participants were vi-
sually reviewed to exclude the presence of macroscopic artifacts. T1-
weighted volumes were pre-processed using the VBM protocol imple-
mented in SPM8 (Statistical Parametrical Mapping, http://www.ﬁl.ion.
ucl.ac.uk/spm/), which consists of an iterative combination of segmen-
tations and normalizations to produce a gray matter probability map
(Ashburner and Friston, 2000, 2005) in standard space (Montreal Neu-
rological Institute, orMNI coordinates) for each subject. In order to com-
pensate for compression or expansion which might occur during
warping of images tomatch the template, graymatter mapsweremod-
ulated by multiplying the intensity of each voxel in the ﬁnal images by
the Jacobian determinant of the transformation, corresponding to its
relative volume before and after warping (Ashburner and Friston,
2001). For each subject, gray matter, white matter, and cerebrospinal
ﬂuid volumes were computed from these probabilistic images. All data
were then smoothed using an 8-mm FWHM Gaussian kernel.
2.8. Statistical analyses
Data analysis was performed with SPSS 22.0 forWindows (SPSS Inc,
USA).
2.9. Questionnaires, behavioral, and HRV analyses
To test for pre-existing group differences, a series of t and χ2 tests
were conducted on self-report socio-demographic and personality
measures.
To test for the effects of the induction on cognitive and autonomic
variables, a series of Group (GAD vs. HC) × Induction (Pre vs. Post) Gen-
eral Linear Models (GLMs) were performed on RT, RMSSD, and each
VAS. Log transformation has been applied to variables that did not
meet the criteria of normality and equal variance (i.e., RTs and HRV).
2.10. VBM analysis
Statistical analyses were performed on smoothed gray matter maps
within the framework of the general linear model. We used a t-test de-
sign implemented in SPM8, to compare graymatter volume in GAD and
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matter volume, gray matter volume, and cerebrospinal ﬂuid volume)
as a nuisance covariate to adjust for potential confounding individual
differences (e.g. in head size). For RT and HRV, we calculated change
scores by subtracting pre induction from post induction scores
(Δ[Post− Pre]). Subsequently, these change scores as well as mindful-
ness facets scores have been entered in SPM8 t-test design as variables
of interest, to explore inwhich regions of the brain graymatter volumes
were associated with our emotion (dys) regulation indices. For each
participant, we next extracted speciﬁc gray matter volume values
from statistically signiﬁcant voxels and reported correlational graphs
for illustrative purposes only.
For a priori region-of-interest (ROI) analyses for bilateral amygdala,
we constructed anatomical masks using the anatomical toolbox for SPM
(Tzourio-Mazoyer et al., 2002). Moreover, we used an anatomically de-
rived (AAL atlas) partial brain mask of entire prefrontal cortex/frontal
lobe. Results were accepted as signiﬁcant at p b 0.05 FWE corrected at
cluster level (cluster formed with p value b 0.005).
3. Results
3.1. Descriptive results
Table 1 illustrates baseline characteristics of the samples. The
groups did not differ in terms of age, years of education, gender dis-
tribution, nicotine consumption, alcohol and caffeine intake, physi-
cal activity, and body-mass index (Table 1). As expected, GAD
participants reported higher levels of state (t(18) = 4.69; p b
0.0001, d = 2.21) and trait anxiety (t(18) = 6.40; p b 0.0001, d =
1.59), trait worry (t(18) = 6.03, p b 0.0001, d = 2.27), andTable 1
Baseline differences between generalized anxiety disorder (GAD) and healthy controls
(HC).
GAD (n = 19) HC (n = 19) p
Age (years) 30 ± 6.9 29.2 ± 9.8 0.81
Gender (M/F) 3/16 3/16 0.67
BMI (kg/m2) 22.80 ± 3.26 23.07 ± 2.97 0.67
Education (years) 13 ± 1.89 12.16 ± 2.52 0.29
Smoking status1 7 Y, 12 N 3 Y, 16 N 0.27
Cigarettes per day (smokers only) 1.74 ± 0.47 2.88 ± 1.26 0.12
Alcohol (units/week) 4.79 ± 4.38 4.04 ± 3.35 0.54
Coffee/caffeinated drinks
(cups/day)
2.42 ± 1.74 2.16 ± 1.92 0.65
Perceived physical ﬁtness2 12 H, 5 M, 2 L 9 H, 9 M, 1 L 0.39
STAI state 43 ± 8.76 29.84 ± 7.81 b0.0001
STAI trait 55.11 ± 8.02 35.89 ± 9.28 b0.0001
BDI 16.53 ± 9.56 4.11 ± 5.07 b0.0003
PSWQ 68.11 ± 8.56 43.47 ± 13.09 b0.0001
HRV (pre-induction) 44.75 ± 21.85 69.92 ± 35.15 0.01
HRV (post-induction) 42.42 ± 16.36 74.82 ± 43.36 0.01
RT (pre-induction) 464.58 ± 83.36 464.47 ±
72.48
0.5
RT (post-induction) 523.58 ±
121.15
505.37 ± 63.0 0.28
VAS (pre-induction)
Ruminating/worrying 33.11 ± 29.43 22.47 ± 22.06 0.11
Focused on task 76.06 ± 19.46 64.68 ± 30.78 0.1
Distracted by external stimuli 56.89 ± 24.35 44.16 ± 28.17 0.07
Distracted by internal thoughts 55.84 ± 29.22 55.16 ± 27.75 0.5
VAS (post-induction)
Ruminating/worrying 66.42 ± 25.11 70.89 ± 21.40 0.27
Focused on task 47.21 ± 25.42 57.79 ± 23.12 0.09
Distracted by external stimuli 42.95 ± 24.87 36.89 ± 28.66 0.24
Distracted by internal thoughts 84.32 ± 12.65 77.16 ± 18.55 0.09
Note: Generalized anxiety disorder = GAD; healthy controls = HC; body mass index =
BMI; State Trait Anxiety Inventory = STAI; Beck Depression Inventory = BDI. Penn
State Worry Questionnaire = PSWQ; heart rate variability = HRV; reaction times = RT;
Visual Analogue Scale = VAS.
1 Y = YES, N = NO.
2 H = High, M =Medium, L = Low.depression (t(18)= 4.59; p b 0.0001, d=1.62). The examined ques-
tionnaires showed adequate internal consistency; Cronbach's α
values in HC and GAD were as follows: 0.89 and 0.92 for STAI state;
0.92 and 0.86 for STAI trait; 0.94 and 0.84 for PSWQ; 0.87 and 0.89
for BDI.
As shown in Fig. 1A, GAD participants had lower scores on the fol-
lowing FFMQ subscales: Act with awareness, t(18) = 3.65, p b 0.01,
d = 1.09, Non judging, t(18) = 6.05, p b 0.0001, d = 1.67 and Non
reactivity, t(18) = 4.56, p b 0.001, d= 1.35. No differences emerged
for the Describing and Observing subscales. Cronbach's α values in
the present study in HC and GAD were as follows: 0.79 and 0.85 for
Act with awareness; 0.90 and 0.92 for Non judging; 0.63 and 0.83
for Non reactivity; 0.93 and 0.78 for Describing; 0.78 and 0.71 for
Observing.
3.2. Behavioral results
Amain effect of Induction emerged, expressed as a decrease in being
focused on task (Pre = 70.22 ± 26.18 vs. Post = 51.84 ± 24.55, F(1,
35) = 18.18, p b 0.0001, ƞp2= .34) and distracted by external stimuli
(Pre = 50.35 ± 26.80 vs. Post = 40.27 ± 26.93; F(1, 35) = 9.78, p =
0.004, ƞp2 = .22), and an increase in perseverative cognition (Pre =
27.79 ± 26.21 vs. Post = 68.65 ± 23.12, F(1, 36) = 83.47, p b 0.0001,
ƞp2 = .69) and being distracted by internal thoughts (Pre = 55.50 ±
28.11 vs. Post= 82.84± 17.05; F(1, 36)= 29.53, p b 0.0001, ƞp2= .45).
A Group × Induction interaction was evident for “being focused on
the task” (F(1, 35)= 7.25, p= 0.01, ƞp2 = .17), driven by a stronger de-
crease in GAD (Pre = 76.10 ± 19.46 vs. Post = 45.55 ± 25.10, t(18) =
5.20, p = 0.001, d = 1.52) compared to HC (Pre = 64.68 ± 30.78 vs.
Post = 57.79 ± 23.12, t(18) b 1). The induction also interfered with at-
tention dependent performance, as evident by amain effect of Induction
indicating a prolongation of RTs in both groups (Pre = 464.52 ± 77.05
vs. Post = 514.47 ± 95.69, F(1, 36) = 24.24, p b 0.001, ƞp2 = 0.41).
GAD patients had lowerHRVwhen compared toHC, as conﬁrmed by
the main effect of Group (GAD = 45.14 ± 16.23 vs. HC = 74.20 ±
41.99; F(1, 36)=8.12, p b 0.001,,ƞp2=0.18). Noother signiﬁcant effects
or interactions emerged.
3.3. Morphometry
Patientswith GAD showed signiﬁcantly lower graymatter volume in
supramarginal gyrus, precentral and postcentral gyrus, bilaterally com-
pared to HC (Fig. 2A, Table 2 (1)). There were no areas of reduced gray
matter volume in HC when compared to GAD.
3.4. Relationship between gray matter volume and mindfulness facets
The volumeof right amygdala reﬂected a between-group interaction
with the ‘Actingwith awareness’mindfulness facet. This interactionwas
driven by a positive correlation in the group of HC,where smaller amyg-
dala volume was associated with a decreased ability to act with aware-
ness (Fig. 2, B1).
Moreover, a signiﬁcant Group × Non reactivity interaction emerged
driven by a positive correlation inGADwhere higher levels of thismind-
fulness skill were associated with increased medial frontal cortex vol-
ume (Fig. 2, B2).
No signiﬁcant associations emerged between structural brain abnor-
malities and the Non judging facet in our sample.
3.5. Relationship between gray matter volume and attentional deﬁcits
(RTs)
As illustrated in Fig. 3A, the prolongation in RTs induced by the in-
duction (ΔRT) was associated with gray matter volume in bilateral
amygdala. Particularly, a Group × ΔRT interaction emerged, driven
by a positive correlation in GAD, and a negative correlation in HC. In
Fig. 1.Differences in FFMQ subscales between individuals with generalized anxiety disorder (GAD) and healthy controls (HC) (A). Effect of the induction (Δ[Post− Pre]) for GAD and HC
on visual analogue scale ratings (VAS; B), reaction times (RT; C), and heart rate variability (HRV; D) measures during the tracking tasks. Note: Distract by Ext = Distracted by external
stimuli; Distract by Int = Distracted by internal thoughts; PC = perseverative cognition. *Although the Group × Induction interaction was not signiﬁcant for the VAS rumination/
worry (PC), ΔPC signiﬁcantly bigger in HC compared to GAD (due to a higher baseline in GAD).
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ciated with augmented volume of the amygdala in GAD and with a
diminished volume of the amygdala in HC. Results did not change
when a non-parametric test was used or extreme outliers were re-
moved from the analyses (ps b 0.01).3.6. Relationship between gray matter volume and autonomic arousal
(HRV)
Although no signiﬁcant associations emerged within the amygdala,
the shift in HRV after the worry induction (ΔHRV) correlated positively
Fig. 2. (A) Generalized anxiety disorder (GAD) reported signiﬁcant gray matter atrophy in bilateral supramarginal/postcentral gyrus compared to healthy controls (HC). (B) Signiﬁcant
association between graymatter volume of (B1) the right amygdala and the Act with awareness facet and (B2) medial frontal cortex volume and the Non-react mindfulness facet. Values
inside square brackets refer to Bootstrap Conﬁdence Intervals.
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cortex, anterior cingulate cortex, and paracingulate gyrus (see Table 2
for a detailed list of brain areas) in GAD patients only, indicating that
smaller graymatter volumes in these areas were associated with a stron-
ger decrease in HRV after the induction (Fig. 3B). Results did not change
when a non-parametric test was used or extreme outliers were removed
from the analyses (ps b 0.01).
4. Discussion
We combined structural neuroimaging analyses with self-report
questionnaires, behavioral measures of attention, and physiologicalindices of autonomic control before and after a perseverative cognition
induction to provide enriched insight into the neural substrates associ-
atedwith core symptoms of emotion dysregulation in GAD. Results con-
ﬁrm the presence of neurobiological abnormalities in these patients,
mainly involving regions implicated in top–down control of directed at-
tention. In addition to this group effect, more speciﬁc gray matter vol-
ume abnormalities were associated with dispositional measures of
mindfulness, impaired attention, and autonomic dysregulation.
In line with previous studies, the induction was effective in increas-
ing state levels of perseverative cognition as well as prolonging RTs,
indexing an impairment of attention-dependent perceptual response
(Ottaviani et al., 2013). Results on baseline differences between the
Table 2
Brain areas showing signiﬁcant correlation between gray matter volume and GAD core symptoms.
Brain region Cluster Voxel
Side k p FWE Z MNI xyz
(1) Reduction in GM volume in GAD relative to HC
Supramarginal gyrus/postcentral gyrus R 549 0.02 4.83 38−34 44
Precentral gyrus R 2.95 52−6 52
Postcentral gyrus L 469 0.04 3.65 −54−22 53
Supramarginal gyrus L 3.54 −54−42 32
Postcentral gyrus L 2.88 −56−20 36
(2) Relationship between FFMQ facets and GM volume (FFMQ × Group)
Act with awareness
Amygdala R 22 0.021,2 3.60 32−2−26
Non-react
Medial frontal cortex R 282 0.0371,2 3.52 8 42−20
(3) Relationship between GM volume and RT (ΔRT × Group)
Amygdala R 87 0.011,2 3.83 30−6−24
L 78 0.031,2 3.42 −20 0−26
L 15 0.031,2 3.42 −28−8−10
(4) Relationship between GM volume and HRV (ΔHRV × Group)
Insula R 1619 0.0001 4.22 40−16 2
L 592 0.0001 3.11 −36 18 0
Precentral gyrus R 3.97 58 2 12
Supramarginal gyrus/superior temporal gyrus R 3.94 66−30 20
Central opercular cortex/postcentral gyrus R 3.64 56−6 16
Planum polare L 3.70 −48 2−8
Frontal opercular cortex L 3.39 −42 22 0
Central opercular cortex L 3.96 −42 4 8
Frontal orbital cortex/insular cortex L 3.16 −28 26−4
Anterior cingulate gyrus R 640 0.0001 3.50 6 26 24
Paracingulate gyrus R 3.48 8 26 42
L 3.14 −4 26 32
Note: Generalized anxiety disorder= GAD; healthy controls=HC; GM= graymatter; Five FacetMindfulness Questionnaire= FFMQ; reaction times= RT; heart rate variability=HRV.
1 Small-volume correction.
2 Peak-level.
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duction effects at behavioral and physiological levels have been
commented on elsewhere (Ottaviani et al., under review) and will not
be repeated here.
In line with previous studies conducted in adolescents (Strawn et al.,
2013), GAD patients were characterized by relative decreases in the vol-
umeof bilateral supramarginal gyrus, postcentral, andprecentral brain re-
gions, compared toHC.Most of these areas are associatedwith top–down
control of attentional focus (Hopﬁnger et al., 2000), hence abnormalities
in their structural integrity might be associated with attentional deﬁcits
linked to excessive worry, as often observed in patients with anxiety dis-
orders (Eysenck et al., 2007). Interestingly, aberrant functional activity
within these areas is observed in the context of other unwanted intrusive
cognitive processes, an extreme example being the experience of auditory
verbal hallucinations in both psychotic and nonpsychotic patients
(Diederen et al., 2012). Whereas previous neuroimaging studies of GAD
report more pronounced volume changes within the right cerebral hemi-
sphere (Hilbert et al., 2014), we observed no systematic group differences
in laterality; the present ﬁndings encompass bilateral areas.
Unexpectedly,we did notﬁnddifferences in amygdala volumewhen
comparing GAD to controls. Although increased gray matter volume
was found in the bilateral amygdala in adults (Etkin et al., 2009;
Schienle et al., 2011), children, and adolescents (De Bellis et al., 2000)
with a diagnosis of GAD, this result has not always been replicated
(Strawn et al., 2013; Mohlman et al., 2009), suggesting the inﬂuence
of clinical factors such as disease duration. Although comparable with
previous investigations, it is possible that our null ﬁnding was simply
due to the small sample size of the present study.
As predicted, regional brain volume abnormalities were associated
with key symptoms of emotion dysregulation in GAD. In line with previ-
ous studies on anxiety disorders, our clinical sample showed lower levels
of ‘Act with awareness’, ‘Non-judging’, and ‘Non-reactivity’ mindfulness
facets, yet no differenceswere observed on theDescribe andObserve sub-
scales (Desrosiers et al., 2013a). Such replication highlights the potentialutility of targeting speciﬁc aspects ofmindfulness in therapeutic interven-
tions for anxiety. We also replicated the results of brain correlates of
mindfulness previously described in healthy participants showing a pos-
itive correlation between mindfulness facets and gray matter volume of
the right amygdala (Lu et al., 2014; Murakami et al., 2012). There are,
however, some controversies regarding this point. For example, a study
of 155 healthy community adults showed a negative correlation between
amygdala volume and dispositional mindfulness (Taren et al., 2013).
Moreover, a reduction in the gray matter density of the right amygdala
has been observed following an 8-week mindfulness-based intervention
(Hölzel et al., 2010). Although many results on general trait measures of
mindfulness are contradictory, increased amygdala volume is otherwise
consistently associated with the expression of speciﬁc mindfulness facets
across healthy individuals. It may be particularly relevant that in our
study ‘act with awareness’ and “non reactivity” emerged to be the only
two facets differently associated with structural differences in GAD and
controls. The presence of this mindfulness facet is particularly beneﬁcial
for reducing negative repetitive thoughts and has been found to be in-
versely associated with worry (Delgado et al., 2010; Fisak and von Lehe,
2012) and general distress-anxiety (Desrosiers et al., 2013b). Interesting-
ly, a positive correlationwas obtained betweenNon reactivity andmedial
frontal cortex volume inGADwhereas no associations emerged inhealthy
controls. This is an intriguing result as this brain area has been implicated
in thought suppression (Wyland et al., 2003) and proactive control
(Stuphorn and Emeric, 2012), which are impaired in GAD and likely
need a larger gray matter volume cortical area to perform well. On the
contrary, in healthy individuals, the adaptive pruning process has likely
improved the efﬁcacy of that region during early development, allowing
a better performance with a more mature (i.e., with smaller gray matter
volume) cortical area.
Effective interventions aimed to enhance control over perseverative
cognition, such as mindfulness based cognitive therapy (MBCT;
(Teasdale, 1999)) have focus on the present moment as their key com-
ponent. In our study, the amygdala was differently associated with ‘Act
Fig. 3. Brain regions presenting signiﬁcant correlations between gray matter density and RTs and HRV changes in response to the induction. (A) A group × ΔRT[Post− Pre] interaction
emerged for bilateral amygdala. The interaction was driven by a positive correlation between ΔRT and gray matter in GAD and a negative correlation between ΔRT and gray matter in
HC. (B) A positive correlation was evident between the shift in HRV (ΔHRV) and gray matter volume in the bilateral insula, bilateral opercular cortex, right precentral/supramarginal
gyrus, anterior cingulate cortex and paracingulate gyrus in GAD only. Values inside square brackets refer to Bootstrap Conﬁdence Intervals.
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correlated with higher scores in HC and this association was lost in
GAD. This is in agreementwith the reported correlation between amyg-
dala volume and ‘sensitivity to punishment’, ameasure of behavioral in-
hibition in response to novelty or punishment cues, which plays an
important role in anxiety. Sensitivity to punishment can arguably be
considered as the opposite of the ‘Act with awareness’ facet (Barrós-
Loscertales et al., 2006).
A similar pattern was observed for our measure of attentional en-
gagement (RT). Not only the induction increased RTs during the atten-
tional task in both GAD and HC but also RT changes from pre to postinduction correlatedwith the graymatter volume in bilateral amygdala.
In GAD, larger volumes of amygdala were associated with slower RTs
after the induction, whereas in HC the opposite pattern was observed,
whereby the stronger impact of the induction on RTs was associated
with smaller volumes of the amygdala. Larger volume in amygdala has
been repeatedly described in anxious children, adolescents (De Bellis
et al., 2000; MacMillan et al., 2003) and adults (Etkin et al., 2009;
Schienle et al., 2011), in whom amygdala volume often correlates with
reported levels of anxiety (Barrós-Loscertales et al., 2006). The observed
difference in the structural integrity of the amygdala might be the con-
sequence of a disorder-related hyper-responsiveness of this structure.
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inversely related during the extinction of conditioned fear (Motzkin
et al., 2015). Disruption of this inverse coupling is commonly observed
in patients with mood and anxiety disorders (Johnstone et al., 2007;
Milad et al., 2006). Speculatively, the enhanced responsivity of the
amygdala during aversive anticipation (Nitschke et al., 2009) might en-
gender an enlargement of amygdala volume. In fact, activity-dependent
changes in graymatter are already widely described in structural imag-
ing studies (Draganski et al., 2004). Nevertheless, the opposite patterns
that emerged for GAD and HC groups suggest a potentially unique neu-
robiology of this psychopathological condition, likely reﬂecting
disorder-speciﬁc symptomatology. Further investigation is warranted
to clarify the contribution of amygdala in these distinctive GAD
symptoms.
A positive correlation was evident between the greater attenuation
of HRV caused by the induction and smaller graymatter volume of bilat-
eral insula, bilateral opercular cortex, right precentral/supramarginal
gyrus, anterior cingulate cortex, and paracingulate gyrus in GAD pa-
tients only. Thus, a negative shift in HRV after the induction was associ-
ated with lower gray matter volumes in these areas. Although studies
on the structural correlates of the HRV are limited, recent evidence sug-
gests insular atrophy in conditions such as postural tachycardia syn-
drome, which is characterized by a wide range of autonomic and
psychiatric symptoms such as palpitations, lightheadedness, clouding
of thought, blurred vision, fatigue, anxiety and depression (Umeda
et al., 2015). The insula is considered a pivotal brain region for these
phenomena, due to its role in receiving and integrating all bodily inputs
(Critchley, 2009).
To the best of our knowledge, this is the ﬁrst study to combine MRI
and peripheral physiology monitoring with the aim of examining the
link between neurostructural abnormalities and different facets of emo-
tion dysregulation in GAD. Taken together, results support the view of
the disruption of common underlying mechanisms, with an important
role played by the amygdala.
The major limitation of the present study is the small sample size,
which increases the likelihood that the whole-brain analyses are capi-
talizing on chance or that the estimate of the magnitude of a signiﬁcant
effect is exaggerated (Button et al., 2013). Another limitation is that
mindfulness was solely assessed by self-rating instruments (Park
et al., 2013). For example, even if none of our GAD participants had a co-
morbid depression disorder, BDI scores were signiﬁcantly higher in the
pathological sample, suggesting the presence of depressive symptoms
that might lead to a subjective underestimation of mindfulness self-
rating. Lastly, some recent reviews have raised a note of caution on
the use of VBM methodology in the study of psychiatric conditions
(Weinberger and Radulescu, in press), which might misinform the
readers on the biological abnormalities underlying psychiatric condi-
tions. Limitations notwithstanding, results inform us about fundamen-
tal changes in brain organization in GAD patients and link them to the
core symptoms of this psychopathological disease. Giving the preva-
lence and chronicity of this disorder in the general population and the
lack of integrative studies on the topic, the elucidation of dysfunctional
brain–body interactions is necessary to increase existing treatment ef-
fectiveness and contribute to the development of targeted
interventions.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2015.11.022.
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